Free Trial
NYSE:ELMD

Electromed 8/22/2023 Earnings Report

Electromed logo
$18.23 -0.42 (-2.25%)
Closing price 07/18/2025 04:00 PM Eastern
Extended Trading
$18.24 +0.00 (+0.03%)
As of 07/18/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Electromed EPS Results

Actual EPS
$0.12
Consensus EPS
$0.10
Beat/Miss
Beat by +$0.02
One Year Ago EPS
N/A

Electromed Revenue Results

Actual Revenue
$13.61 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Electromed Announcement Details

Quarter
Time
Q4 2023 Earnings Release
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Electromed Earnings Headlines

Congress Is Talking Crypto. Here’s What It Means for You …
Congress is deep into “Crypto Week” — with new bills that could finally bring clarity to digital assets. Crypto analyst Juan Villaverde says Bitcoin will likely keep climbing… but smaller coins could deliver far bigger gains. He’s revealing the altcoins he believes are best positioned for this new regulatory era.
See More Electromed Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Electromed? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Electromed and other key companies, straight to your email.

About Electromed

Electromed (NYSE:ELMD) is a medical technology company specializing in the development, manufacturing and distribution of respiratory support and diagnostic systems. The company’s flagship offering, the The Vest® Airway Clearance System, employs High Frequency Chest Wall Oscillation (HFCWO) therapy to assist patients in clearing mucus from their lungs. In addition to its core respiratory care products, Electromed provides a suite of diagnostic monitoring and biofeedback devices designed to complement its therapeutic portfolio and support clinicians in optimizing patient outcomes.

Founded in 1990 and headquartered in Cleveland, Ohio, Electromed has grown from a single-product enterprise to a diversified medical device manufacturer. Over the decades, the company has expanded its product pipeline through both in-house research and strategic collaborations with academic institutions and clinical centers. Electromed’s manufacturing operations adhere to rigorous quality standards, including FDA and ISO certifications, ensuring that its devices meet stringent safety and efficacy requirements.

Electromed’s market presence spans North America, Europe and select Asia-Pacific regions. The company leverages a combination of direct sales teams, contracted distributors and strategic partnerships to serve hospitals, outpatient clinics and home healthcare providers. By tailoring its sales and marketing initiatives to regional regulatory landscapes and reimbursement environments, Electromed aims to facilitate broader patient access to its respiratory care solutions.

Guided by an experienced management team with deep expertise in medical device innovation, regulatory affairs and reimbursement strategy, Electromed continues to invest in research and development. The company’s leadership emphasizes collaboration with healthcare professionals and patient advocacy groups to refine existing technologies and explore new applications for airway clearance therapy. Electromed remains committed to advancing respiratory health through ongoing product enhancements and a focus on evidence-based care.

View Electromed Profile

More Earnings Resources from MarketBeat